Related Experiment Video
Updated: Jun 21, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Understanding the relationship between HCV infection and progression of kidney disease
Meiqi Zhang1, Zhongyu Han1,2, Yumeng Lin2
1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Insights
Hepatitis C virus (HCV) causes kidney diseases like glomerulonephritis and vasculitis. Direct-acting antiviral agents (DAAs) offer effective treatment options for these HCV-related kidney conditions.
Area of Science:
- Nephrology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) is a significant cause of kidney disease.
- HCV is the leading cause of mixed cryoglobulinaemia, leading to vasculitis and glomerulonephritis.
- HCV infection is linked to acute kidney injury, chronic kidney disease, and end-stage renal disease.
Purpose of the Study:
- To review current findings on Hepatitis C virus and kidney disease.
- To discuss the therapeutic impact of direct-acting antiviral agents (DAAs) on HCV-related kidney conditions.
- To identify areas for future research and treatment strategies.
Main Methods:
- Literature review of studies on HCV and kidney disease.
- Analysis of clinical data on the efficacy of DAAs.
- Synthesis of information on pathogenesis and clinical outcomes.
Main Results:
- HCV infection is a primary driver of cryoglobulinaemic vasculitis and glomerulonephritis.
- HCV significantly increases the risk of acute kidney injury, chronic kidney disease, and end-stage renal disease.
- DAAs demonstrate high efficacy in treating HCV infection across different stages of kidney disease.
Conclusions:
- HCV poses a substantial threat to kidney health through various mechanisms.
- DAAs represent a breakthrough in managing HCV-related kidney diseases.
- Further research is needed to optimize treatment and address long-term outcomes.
Abstract:
Hepatitis C virus (HCV) can cause a range of kidney diseases. HCV is the primary cause of mixed cryoglobulinaemia, which leads to cryoglobulinaemic vasculitis and cryoglobulinaemic glomerulonephritis (GN). Patients with acute cryoglobulinaemic vasculitis often exhibit acute kidney disease due to HCV infection, which typically progresses to acute kidney injury (AKI). HCV also increases the risk of chronic kidney disease (CKD) and the likelihood of developing end-stage renal disease (ESRD). Currently, direct-acting antiviral agents (DAAs) can be used to treat kidney disease at different stages. This review focuses on key findings regarding HCV and kidney disease, discusses the impact of DAAs, and highlights the need for further research and treatment.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Nephrons
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Retrovirus Life Cycles

